Anticholinergic agent / Muscarinic receptor antagonist

5 marketed 4 in Phase 3

This page covers all Anticholinergic agent / Muscarinic receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptors (M1, M3, M5), M2 and M3 muscarinic receptors, M2 and M3 muscarinic acetylcholine receptors.

Targets

Muscarinic acetylcholine receptors (M1, M3, M5) · M2 and M3 muscarinic receptors · M2 and M3 muscarinic acetylcholine receptors · Muscarinic acetylcholine receptors (M1-M5, primarily M3 in ocular tissue) · M3 muscarinic receptor · Muscarinic acetylcholine receptors (M1-M5, primarily M1 and M3) · Muscarinic acetylcholine receptors (M1-M5) · Muscarinic acetylcholine receptors (M1, M3)

Marketed (5)

Phase 3 pipeline (4)

Patent intelligence